Literature DB >> 23065261

Prognostic impact of Metadherin-SND1 interaction in colon cancer.

Nan Wang1, Xilin Du, Li Zang, Nuan Song, Tao Yang, Rui Dong, Tao Wu, Xianli He, Jianguo Lu.   

Abstract

The interaction between Metadherin (MTDH) and Staphylococcal nuclease homology domain containing 1 (SND1) is involved in tumorigenesis and tumor progression of several human malignancies. However, its roles in colon cancer are still unclear. To investigate the clinical value of MTDH and SND1 expression in colon cancer. Immunohistochemical staining was performed to detect the expression of MTDH and SND1 using human colon cancer and their corresponding non-cancerous colon tissues from 196 patients' biopsies. Positive expression of MTDH and SND1 were both increased in colon cancer tissues compared to paired non-cancerous colon tissues. There was a positive correlation between MTDH and SND1 expression in colon cancer tissues (r = 0.86, p < 0.001). In addition, their positive expression were both significantly associated with nodal status (both p = 0.02), pathological stage (p = 0.006 and 0.008, respectively) and differentiation (both p = 0.03). Moreover, the overall survival in colon cancer patients with positive expression of MTDH and SND1 were significantly shorter than those without their expression (both p = 0.01). Furthermore, multivariate Cox regression analysis suggested that positive expression of MTDH and SND1 was an independent poor prognostic predictor in colon cancer. Our data suggest that the increased expression of MTDH and/or SND1 is closely related to carcinogenesis, progression, and prognosis of colon cancer. The co-expression of MTDH/SND1 may be a novel distinctive marker to benefit us in prediction of the prognosis in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065261     DOI: 10.1007/s11033-012-1933-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Role of dendritic cells in progression and clinical outcome of colon cancer.

Authors:  Maya V Gulubova; Julian R Ananiev; Tatyana I Vlaykova; Yovcho Yovchev; Vanya Tsoneva; Irena M Manolova
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

2.  Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma.

Authors:  Cong Li; Yinghong Li; Xiaochuan Wang; Zhenyu Wang; Jianping Cai; Lihua Wang; Yulan Zhao; Hongtao Song; Xiangning Meng; Xiaoming Ning; Chunlin Xu; Mei Lin; Lejing Li; Jingshu Geng
Journal:  Histopathology       Date:  2012-02-28       Impact factor: 5.087

3.  Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

Authors:  Angela B Y Hui; Jeff P Bruce; Nehad M Alajez; Wei Shi; Shijun Yue; Bayardo Perez-Ordonez; Wei Xu; Brian O'Sullivan; John Waldron; Bernard Cummings; Patrick Gullane; Lillian Siu; Fei-Fei Liu
Journal:  Clin Cancer Res       Date:  2011-10-26       Impact factor: 12.531

4.  Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.

Authors:  Shijun Sun; Zunfu Ke; Fen Wang; Shuhua Li; Wenfang Chen; Anjia Han; Zuo Wang; Huijuan Shi; Lian-Tang Wang; Xiaodong Chen
Journal:  Hum Pathol       Date:  2011-12-26       Impact factor: 3.466

Review 5.  Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology.

Authors:  Byoung Kwon Yoo; Luni Emdad; Seok-Geun Lee; Zao-zhong Su; Prasanna Santhekadur; Dong Chen; Rachel Gredler; Paul B Fisher; Devanand Sarkar
Journal:  Pharmacol Ther       Date:  2011-01-20       Impact factor: 12.310

6.  Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.

Authors:  Mario Andres Blanco; Masa Alečković; Yuling Hua; Tuo Li; Yong Wei; Zhen Xu; Ileana M Cristea; Yibin Kang
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

7.  Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.

Authors:  Byoung Kwon Yoo; Prasanna K Santhekadur; Rachel Gredler; Dong Chen; Luni Emdad; Sujit Bhutia; Lewis Pannell; Paul B Fisher; Devanand Sarkar
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

8.  Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy.

Authors:  Sujit K Bhutia; Timothy P Kegelman; Swadesh K Das; Belal Azab; Zhao-Zhong Su; Seok-Geun Lee; Devanand Sarkar; Paul B Fisher
Journal:  Autophagy       Date:  2011-05-01       Impact factor: 16.016

9.  Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

Authors:  Chunping Yu; Kun Chen; Haiqing Zheng; Xianzhi Guo; Weihua Jia; Manzhi Li; Musheng Zeng; Jun Li; Libing Song
Journal:  Carcinogenesis       Date:  2009-03-20       Impact factor: 4.944

10.  Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.

Authors:  Yuhan Zhao; Xiaoli Kong; Xiaoyan Li; Shi Yan; Cunzhong Yuan; Wenwei Hu; Qifeng Yang
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

View more
  24 in total

1.  SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.

Authors:  L Yu; Y Di; L Xin; Y Ren; X Liu; X Sun; W Zhang; Z Yao; J Yang
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

2.  miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1.

Authors:  Junrong Wang; Yubo Hu; Cong Ye; Junbao Liu
Journal:  Hum Cell       Date:  2020-05-14       Impact factor: 4.174

Review 3.  AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.

Authors:  Seok-Geun Lee; Dong-Chul Kang; Rob DeSalle; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 4.  AEG-1/MTDH/LYRIC: clinical significance.

Authors:  Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

5.  AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.

Authors:  Luni Emdad; Swadesh K Das; Santanu Dasgupta; Bin Hu; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 6.  The role of MTDH/AEG-1 in the progression of cancer.

Authors:  Xue Shi; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.

Authors:  Lin Yu; Jinling Xu; Jing Liu; Huibian Zhang; Cuiyun Sun; Qian Wang; Cuijuan Shi; Xuexia Zhou; Dan Hua; Wenjun Luo; Xiuwu Bian; Shizhu Yu
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

8.  Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.

Authors:  Vladimir A Naumov; Edward V Generozov; Natalya B Zaharjevskaya; Darya S Matushkina; Andrey K Larin; Stanislav V Chernyshov; Mikhail V Alekseev; Yuri A Shelygin; Vadim M Govorun
Journal:  Epigenetics       Date:  2013-07-17       Impact factor: 4.528

Review 9.  Tudor staphylococcal nuclease: biochemistry and functions.

Authors:  Emilio Gutierrez-Beltran; Tatiana V Denisenko; Boris Zhivotovsky; Peter V Bozhkov
Journal:  Cell Death Differ       Date:  2016-09-09       Impact factor: 15.828

10.  Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.

Authors:  Luni Emdad; Aleksandar Janjic; Mohammad A Alzubi; Bin Hu; Prasanna K Santhekadur; Mitchell E Menezes; Xue-Ning Shen; Swadesh K Das; Devanand Sarkar; Paul B Fisher
Journal:  Neuro Oncol       Date:  2014-09-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.